KenSci raises $22m to predict patients’ risk of illness (and save hospitals money)

KenSci, a Seattle-based startup that uses AI to predict patients’ risk of illness, raised $22m.

February 8, 2019

The days of maverick, cane-wielding doctors riding on a hunch and a whiteboard to make medical decisions may be numbered — at least, if KenSci, an artificial intelligence startup out of Seattle, has anything to say about it.

3-year-old KenSci just raised a $22m Series B to advance its predictive AI platform, which uses aggregate data to forecast patient risk for things like sepsis, heart attacks, and even cancer.

Armed with a hashtag (#deathvsdatascience) and a dream, KenSci seems poised to take the ward by storm. 

It’s a win for patients, but it’s an even bigger win for hospitals

KenSci provides a “risk prediction” dashboard for healthcare practitioners to track cost of care, no-show appointments, and readmission rates — all in the hopes of lowering expenses for providers.

And a little help with resourcing could go a long way: VentureBeat writes that in 2017, US health care costs hit $3.5T (17.9% of the US’ GDP).

It also has potential to help doctors make bigger patient decisions… 

Like when it’s time to throw in the towel 

Research from KenSci shows that patients on average “transitioned to end-of-life care too late: 28% of patients transferred to hospices died or were discharged within a week.”

In other words, KenSci’s system could use data to predict mortality rates and make heretofore personal decisions between a patient and doctor about their end-of-life care more quantitative.

Join 1.5m+ professionals getting The Hustle daily news brief

Business and tech news in 5 minutes or less

100% free, no ads or spam, unsubscribe anytime


How'd Bezos build a billion dollar empire?

In 1994, Jeff Bezos discovered a shocking stat: Internet usage grew 2,300% per year.

Data shows where markets are headed.

And that’s why we built Trends — to show you up-and-coming market opportunities about to explode. Interested?

Join us, it's free.

Look, you came to this site because you saw something cool. But here’s the deal. This site is actually a daily email that covers the important news in business, tech, and culture.

So, if you like what you’re reading, give the email a try.

If you don’t like it, unsubscribe any time. Privacy policy.